{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:18:53Z","timestamp":1788175133506,"version":"build-2803163510"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Cultivation projects"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Oncol."],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s13402-025-01099-w","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T13:15:25Z","timestamp":1755609325000},"page":"1609-1614","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Molecular stratification of prostate cancer through sensory perception-related multi-omics analysis reveals chemoresistant mechanisms"],"prefix":"10.1007","volume":"48","author":[{"given":"Shi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,19]]},"reference":[{"issue":"3","key":"1099_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"H. Sung, Global Cancer Statistics 2020 et al., GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71(3), 209\u2013249 (2021)","journal-title":"CA Cancer J. Clin."},{"issue":"24","key":"1099_CR2","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1056\/NEJMoa1807801","volume":"379","author":"A Bill-Axelson","year":"2018","unstructured":"A. Bill-Axelson et al., Radical prostatectomy or watchful waiting in prostate Cancer \u2013 29-Year Follow-up. N Engl. J. Med. 379(24), 2319\u20132329 (2018)","journal-title":"N Engl. J. Med."},{"key":"1099_CR3","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1186\/1477-7819-10-249","volume":"10","author":"E Okajima","year":"2012","unstructured":"E. Okajima et al., Improvement of the surgical curability of locally confined prostate cancer including non-organ-confined high-risk disease through retropubic radical prostatectomy with intentional wide resection. World J. Surg. Oncol. 10, 249 (2012)","journal-title":"World J. Surg. Oncol."},{"key":"1099_CR4","doi-asserted-by":"crossref","unstructured":"N. Tanaka et al., Calculated tumor volume is an independent predictor of biochemical recurrence in patients who underwent retropubic radical prostatectomy. Adv Urol. 2012, 204215 (2012)","DOI":"10.1155\/2012\/204215"},{"issue":"4","key":"1099_CR5","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1093\/nar\/gkx1306","volume":"46","author":"Y He","year":"2018","unstructured":"Y. He et al., Androgen receptor splice variants bind to constitutively open chromatin and promote abiraterone-resistant growth of prostate cancer. Nucleic Acids Res. 46(4), 1895\u20131911 (2018)","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"1099_CR6","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.eururo.2019.09.019","volume":"77","author":"A Thiery-Vuillemin","year":"2020","unstructured":"A. Thiery-Vuillemin et al., Impact of abiraterone acetate plus prednisone or enzalutamide on Patient-reported outcomes in patients with metastatic Castration-resistant prostate cancer: final 12-mo analysis from the observational AQUARiUS study. Eur. Urol. 77(3), 380\u2013387 (2020)","journal-title":"Eur. Urol."},{"issue":"8","key":"1099_CR7","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1002\/cac2.12321","volume":"42","author":"L Wu","year":"2022","unstructured":"L. Wu et al., The establishment of polypeptide PSMA-targeted chimeric antigen receptor-engineered natural killer cells for castration-resistant prostate cancer and the induction of ferroptosis-related cell death. Cancer Commun. (Lond). 42(8), 768\u2013783 (2022)","journal-title":"Cancer Commun. (Lond)"},{"issue":"8","key":"1099_CR8","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s11912-021-01084-0","volume":"23","author":"KD Runcie","year":"2021","unstructured":"K.D. Runcie, M.C. Dallos, Prostate cancer Immunotherapy-Finally in from the cold?? Curr. Oncol. Rep. 23(8), 88 (2021)","journal-title":"Curr. Oncol. Rep."},{"issue":"11","key":"1099_CR9","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1111\/j.1742-1241.2011.02799.x","volume":"65","author":"M Kirby","year":"2011","unstructured":"M. Kirby, C. Hirst, E.D. Crawford, Characterising the castration-resistant prostate cancer population: a systematic review. Int. J. Clin. Pract. 65(11), 1180\u20131192 (2011)","journal-title":"Int. J. Clin. Pract."},{"key":"1099_CR10","doi-asserted-by":"publisher","first-page":"603","DOI":"10.3389\/fimmu.2019.00603","volume":"10","author":"N Vitkin","year":"2019","unstructured":"N. Vitkin, S. Nersesian, D.R. Siemens, M. Koti, The tumor immune contexture of prostate cancer. Front. Immunol. 10, 603 (2019)","journal-title":"Front. Immunol."},{"key":"1099_CR11","doi-asserted-by":"publisher","unstructured":"B. Xu, L. Tao, J. Sun, J. Yang, F. Meng, Z. Zhong, DNA damage repair inhibitors boost targeted radionuclide therapy and immunotherapy of prostate cancer. Apoptosis. Published online June 26, 2025. https:\/\/doi.org\/10.1007\/s10495-025-02136-7","DOI":"10.1007\/s10495-025-02136-7"},{"issue":"4","key":"1099_CR12","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41568-020-0246-1","volume":"20","author":"M McLaughlin","year":"2020","unstructured":"M. McLaughlin, E.C. Patin, M. Pedersen, A. Wilkins, M.T. Dillon, A.A. Melcher, K.J. Harrington, Inflammatory microenvironment remodelling by tumour cells after radiotherapy. Nat. Rev. Cancer. 20(4), 203\u2013217 (2020)","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"1099_CR13","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.trecan.2024.01.004","volume":"10","author":"DH Angappulige","year":"2024","unstructured":"D.H. Angappulige, N.P. Mahajan, K. Mahajan, Epigenetic underpinnings of tumor-immune dynamics in prostate cancer immune suppression. Trends Cancer. 10(4), 369\u2013381 (2024)","journal-title":"Trends Cancer"},{"issue":"1","key":"1099_CR14","doi-asserted-by":"publisher","first-page":"8569","DOI":"10.1038\/s41467-024-52902-5","volume":"15","author":"L Tan","year":"2024","unstructured":"L. Tan, T. Yin, H. Xiang, L. Wang, P. Mudgal, J. Chen, Y. Ding, G. Wang, B.J.W. Lim, Y. Huang, D. Huang, Y. Liang, P.B. Alexander, K. Xiang, E. Wang, C. Yan, Z. Ma, M. Tan, Q.J. Li, X.F. Wang, Aberrant cytoplasmic expression of UHRF1 restrains the MHC-I-mediated anti-tumor immune response. Nat. Commun. 15(1), 8569 (2024)","journal-title":"Nat. Commun."},{"issue":"1","key":"1099_CR15","doi-asserted-by":"publisher","first-page":"8867","DOI":"10.1038\/s41467-024-52555-4","volume":"15","author":"S Sahni","year":"2024","unstructured":"S. Sahni, B. Wang, D. Wu, S.R. Dhruba, M. Nagy, S. Patkar, I. Ferreira, C.P. Day, K. Wang, E. Ruppin, A machine learning model reveals expansive downregulation of ligand-receptor interactions that enhance lymphocyte infiltration in melanoma with developed resistance to immune checkpoint Blockade. Nat. Commun. 15(1), 8867 (2024)","journal-title":"Nat. Commun."},{"issue":"25","key":"1099_CR16","doi-asserted-by":"publisher","first-page":"e2417593","DOI":"10.1002\/advs.202417593","volume":"12","author":"D Zeng","year":"2025","unstructured":"D. Zeng, Y. Yu, W. Qiu, Q. Ou, Q. Mao, L. Jiang, J. Wu, J. Wu, H. Luo, P. Luo, W. Gu, N. Huang, S. Zheng, S. Li, Y. Lai, X. Huang, Y. Fang, Q. Zhao, R. Zhou, H. Sun, W. Zhang, J. Bin, Y. Liao, M. Yamamoto, T. Tsukamoto, S. Nomura, M. Shi, W. Liao, Immunotyping the tumor microenvironment reveals molecular heterogeneity for personalized immunotherapy in cancer. Adv. Sci. (Weinh). 12(25), e2417593 (2025)","journal-title":"Adv. Sci. (Weinh)"},{"issue":"2","key":"1099_CR17","doi-asserted-by":"publisher","first-page":"e70011","DOI":"10.1002\/imt2.70011","volume":"4","author":"B Ye","year":"2025","unstructured":"B. Ye, J. Fan, L. Xue, Y. Zhuang, P. Luo, A. Jiang, J. Xie, Q. Li, X. Liang, J. Tan, S. Zhao, W. Zhou, C. Ren, H. Lin, P. Zhang, iMLGAM: integrated machine learning and genetic Algorithm-driven multiomics analysis for pan-cancer immunotherapy response prediction. Imeta. 4(2), e70011 (2025)","journal-title":"Imeta"},{"issue":"2","key":"1099_CR18","doi-asserted-by":"publisher","first-page":"e010787","DOI":"10.1136\/jitc-2024-010787","volume":"13","author":"P Zhang","year":"2025","unstructured":"P. Zhang, D. Wang, G. Zhou, S. Jiang, G. Zhang, L. Zhang, Z. Zhang, Novel post-translational modification learning signature reveals B4GALT2 as an immune exclusion regulator in lung adenocarcinoma. J. Immunother Cancer. 13(2), e010787 (2025)","journal-title":"J. Immunother Cancer"},{"issue":"1","key":"1099_CR19","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1186\/s12967-023-04683-6","volume":"21","author":"K Zheng","year":"2023","unstructured":"K. Zheng, Y. Hai, Y. Xi, Y. Zhang, Z. Liu, W. Chen, X. Hu, X. Zou, J. Hao, Integrative multi-omics analysis unveils stemness-associated molecular subtypes in prostate cancer and pan-cancer: prognostic and therapeutic significance. J. Transl Med. 21(1), 789 (2023)","journal-title":"J. Transl Med."},{"issue":"8","key":"1099_CR20","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.7150\/ijbs.59918","volume":"17","author":"L Li","year":"2021","unstructured":"L. Li et al., The impact of TRPV1 on cancer pathogenesis and therapy: A systematic review. Int. J. Biol. Sci. 17(8), 2034\u20132049 (2021)","journal-title":"Int. J. Biol. Sci."},{"issue":"3","key":"1099_CR21","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1002\/jcp.25929","volume":"233","author":"Z Chen","year":"2018","unstructured":"Z. Chen et al., The diversified function and potential therapy of ectopic olfactory receptors in non-olfactory tissues. J. Cell. Physiol. 233(3), 2104\u20132115 (2018)","journal-title":"J. Cell. Physiol."},{"issue":"19","key":"1099_CR22","doi-asserted-by":"publisher","first-page":"14989","DOI":"10.3390\/ijms241914989","volume":"24","author":"Y Capodanno","year":"2023","unstructured":"Y. Capodanno, M. Hirth, Targeting the cancer-Neuronal crosstalk in the pancreatic cancer microenvironment. Int. J. Mol. Sci. 24(19), 14989 (2023)","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"1099_CR23","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.trecan.2025.01.003","volume":"11","author":"AA Martel Matos","year":"2025","unstructured":"A.A. Martel Matos, N.N. Scheff, Sensory neurotransmission and pain in solid tumor progression. Trends Cancer. 11(4), 309\u2013320 (2025)","journal-title":"Trends Cancer"},{"issue":"8028","key":"1099_CR24","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41586-024-07767-5","volume":"633","author":"V Padmanaban","year":"2024","unstructured":"V. Padmanaban, I. Keller, E.S. Seltzer, B.N. Ostendorf, Z. Kerner, S.F. Tavazoie, Neuronal substance P drives metastasis through an extracellular RNA-TLR7 axis. Nature. 633(8028), 207\u2013215 (2024)","journal-title":"Nature"},{"issue":"6","key":"1099_CR25","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1002\/j.1532-2149.2013.00420.x","volume":"18","author":"Y Li","year":"2014","unstructured":"Y. Li, J. Cai, Y. Han, X. Xiao, X.L. Meng, L. Su, F.Y. Liu, G.G. Xing, Y. Wan, Enhanced function of TRPV1 via up-regulation by insulin-like growth factor-1 in a rat model of bone cancer pain. Eur. J. Pain. 18(6), 774\u2013784 (2014)","journal-title":"Eur. J. Pain"},{"issue":"5","key":"1099_CR26","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41422-025-01098-4","volume":"35","author":"K Wang","year":"2025","unstructured":"K. Wang, B. Ni, Y. Xie, Z. Li, L. Yuan, C. Meng, T. Zhao, S. Gao, C. Huang, H. Wang, Y. Ma, T. Zhou, Y. Feng, A. Chang, C. Yang, J. Yu, W. Yu, F. Zang, Y. Zhang, R.R. Ji, X. Wang, J. Hao, Nociceptor neurons promote PDAC progression and cancer pain by interaction with cancer-associated fibroblasts and suppression of natural killer cells. Cell. Res. 35(5), 362\u2013380 (2025)","journal-title":"Cell. Res."},{"key":"1099_CR27","doi-asserted-by":"publisher","first-page":"120305","DOI":"10.1016\/j.lfs.2022.120305","volume":"291","author":"N Erin","year":"2022","unstructured":"N. Erin, M. Akman, E. Aliyev, G. Tanr\u0131\u00f6ver, A.F. Korcum, Olvanil activates sensory nerve fibers, increases T cell response and decreases metastasis of breast carcinoma. Life Sci. 291, 120305 (2022)","journal-title":"Life Sci."},{"issue":"4","key":"1099_CR28","doi-asserted-by":"publisher","first-page":"e141335","DOI":"10.1172\/JCI141335","volume":"131","author":"S Lv","year":"2021","unstructured":"S. Lv, Q. Song, G. Chen, E. Cheng, W. Chen, R. Cole, Z. Wu, L.E. Pascal, K. Wang, P. Wipf, J.B. Nelson, Q. Wei, W. Huang, Z. Wang, Regulation and targeting of androgen receptor nuclear localization in castration-resistant prostate cancer. J. Clin. Invest. 131(4), e141335 (2021)","journal-title":"J. Clin. Invest."},{"issue":"16","key":"1099_CR29","doi-asserted-by":"publisher","first-page":"9519","DOI":"10.1093\/nar\/gkae653","volume":"52","author":"KM Launonen","year":"2024","unstructured":"K.M. Launonen, V. Varis, N. Aaltonen, E.A. Niskanen, M. Varjosalo, V. Paakinaho, J.J. Palvimo, Central role of sumoylation in the regulation of chromatin interactions and transcriptional outputs of the androgen receptor in prostate cancer cells. Nucleic Acids Res. 52(16), 9519\u20139535 (2024)","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"1099_CR30","doi-asserted-by":"publisher","first-page":"714","DOI":"10.7150\/thno.88057","volume":"14","author":"I Gorodetska","year":"2024","unstructured":"I. Gorodetska, A. Offermann, J. P\u00fcschel, V. Lukiyanchuk, D. Gaete, A. Kurzyukova, V. Freytag, M.T. Haider, C.S. Fjeldbo, Di S. Gaetano, F.M. Schwarz, S. Patil, A. Borkowetz, H.H.H. Erb, A. Baniahmad, J. Mircetic, H. Lyng, S. L\u00f6ck, A. Linge, T. Lange, F. Knopf, B. Wielockx, M. Krause, S. Perner, A. Dubrovska, ALDH1A1 drives prostate cancer metastases and radioresistance by interplay with AR- and RAR-dependent transcription. Theranostics. 14(2), 714\u2013737 (2024)","journal-title":"Theranostics"},{"issue":"8","key":"1099_CR31","doi-asserted-by":"publisher","first-page":"107451","DOI":"10.1016\/j.isci.2023.107451","volume":"26","author":"Y Li","year":"2023","unstructured":"Y. Li et al., TSC22D3 as an immune-related prognostic biomarker for acute myeloid leukemia. iScience. 26(8), 107451 (2023)","journal-title":"iScience"},{"issue":"1","key":"1099_CR32","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12943-018-0928-4","volume":"18","author":"X Jiang","year":"2019","unstructured":"X. Jiang et al., Role of the tumor microenvironment in PD-L1\/PD-1-mediated tumor immune escape. Mol. Cancer. 18(1), 10 (2019)","journal-title":"Mol. Cancer"},{"issue":"1","key":"1099_CR33","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.clim.2012.10.008","volume":"146","author":"S Iwamoto","year":"2013","unstructured":"S. Iwamoto et al., TNF-\u03b1 is essential in the induction of fatal autoimmune hepatitis in mice through upregulation of hepatic CCL20 expression. Clin. Immunol. 146(1), 15\u201325 (2013)","journal-title":"Clin. Immunol."},{"issue":"1","key":"1099_CR34","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41392-023-01337-3","volume":"8","author":"R Zhang","year":"2023","unstructured":"R. Zhang et al., PMN-MDSCs modulated by CCL20 from cancer cells promoted breast cancer cell stemness through CXCL2-CXCR2 pathway. Signal. Transduct. Target. Ther. 8(1), 97 (2023)","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"7","key":"1099_CR35","doi-asserted-by":"publisher","first-page":"e2005869","DOI":"10.1371\/journal.pbio.2005869","volume":"16","author":"W Chen","year":"2018","unstructured":"W. Chen et al., CCL20 triggered by chemotherapy hinders the therapeutic efficacy of breast cancer. PLoS Biol. 16(7), e2005869 (2018)","journal-title":"PLoS Biol."}],"container-title":["Cellular Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-025-01099-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13402-025-01099-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-025-01099-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T10:45:17Z","timestamp":1760525117000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13402-025-01099-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,19]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["1099"],"URL":"https:\/\/doi.org\/10.1007\/s13402-025-01099-w","relation":{},"ISSN":["2211-3428","2211-3436"],"issn-type":[{"value":"2211-3428","type":"print"},{"value":"2211-3436","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,19]]},"assertion":[{"value":"9 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study adheres to the principles outlined in the Declaration of Helsinki and was conducted following approval from the Ethics Committee of Central Hospital of Dalian University of Technology (Approval No. 2025-106-01). Written informed consent was obtained from all participating patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}